STRS Ohio’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-15,700
| Closed | -$72K | – | 2285 |
|
|
2021
Q2 | $72K | Sell |
15,700
-103,100
| -87% | -$497K | ﹤0.01% | 2046 |
|
|
2021
Q1 | $697K | Sell |
118,800
-86,100
| -42% | -$596K | ﹤0.01% | 1424 |
|
|
2020
Q4 | $700K | Sell |
204,900
-108,400
| -35% | -$207K | ﹤0.01% | 1278 |
|
|
2020
Q3 | $451K | Buy |
313,300
+80,100
| +34% | +$143K | ﹤0.01% | 1393 |
|
|
2020
Q2 | $465K | Buy |
233,200
+70,400
| +43% | +$138K | ﹤0.01% | 1357 |
|
|
2020
Q1 | $317K | Buy |
162,800
+33,900
| +26% | +$101K | ﹤0.01% | 1426 |
|
|
2019
Q4 | $534K | Buy |
+128,900
| New | +$496K | ﹤0.01% | 1417 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 1998 |
|
|
2017
Q1 | – | Sell |
-50,400
| Closed | -$748K | – | 1909 |
|
|
2016
Q4 | $697K | Buy |
50,400
+7,200
| +17% | +$116K | ﹤0.01% | 1126 |
|
|
2016
Q3 | $780K | Sell |
43,200
-11,500
| -21% | -$185K | ﹤0.01% | 951 |
|
|
2016
Q2 | $784K | Sell |
54,700
-3,400
| -6% | -$46.1K | ﹤0.01% | 938 |
|
|
2016
Q1 | $694K | Buy |
58,100
+57,744
| +16,220% | +$605K | ﹤0.01% | 1013 |
|
|
2015
Q4 | $4K | Hold |
356
| – | – | ﹤0.01% | 1896 |
|
|
2015
Q3 | $3K | Hold |
356
| – | – | ﹤0.01% | 1865 |
|
|
2015
Q2 | $2K | Hold |
356
| – | – | ﹤0.01% | 1854 |
|
|
2015
Q1 | $2K | Hold |
356
| – | – | ﹤0.01% | 1799 |
|
|
2014
Q4 | $2K | Hold |
356
| – | – | ﹤0.01% | 1732 |
|
|
2014
Q3 | $4K | Hold |
356
| – | – | ﹤0.01% | 1772 |
|
|
2014
Q2 | $4K | Hold |
356
| – | – | ﹤0.01% | 1684 |
|
|
2014
Q1 | $4K | Hold |
356
| – | – | ﹤0.01% | 1701 |
|
|
2013
Q4 | $4K | Sell |
356
-43
| -11% | -$684 | ﹤0.01% | 1727 |
|
|
2013
Q3 | $7K | Hold |
399
| – | – | ﹤0.01% | 1812 |
|
|
2013
Q2 | $6K | Buy |
+399
| New | +$6.06K | ﹤0.01% | 1821 |
|
Other funds holding LXRX
AG
BI
NMC
PA
